PDF herunterladen
Thromb Haemost 1994; 72(04): 650-651
DOI: 10.1055/s-0038-1648935
Letter to the Editor
Schattauer GmbH Stuttgart

Why Is Plasma Fibrinogen a Cardiovascular Risk Factor?

Michael C Scrutton
Division of Life Sciences, King’s College, London, UK
,
Simon B Ross-Murphy
Division of Life Sciences, King’s College, London, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 24. Mai 1994

Accepted 23. Juni 1994

Publikationsdatum:
06. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Ceriello A, Pirisi M, Giacomello R, Stel G, Falleti E, Motz E, Lizzio S, Gonano F, Bartoli E. Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemostas 1994; 71: 593-595
    PubMedGoogle Scholar
  • 2 Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovich M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; i: 1050-1054
    PubMedGoogle Scholar
  • 3 Wilhelmsen L, Svardsudd K, Korsan-Bengtsson K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. New Eng J Med 1984; 311: 501-505
    CrossrefPubMedGoogle Scholar
  • 4 Scrutton MC, Ross-Murphy SB, Bennet GM, Stirling Y, Meade TW. Changes in clot deformability: a possible explanation for the role of the plasma fibrinogen concentration in myocardial infarction. Brit J Haematol 1994; 86 suppl (Suppl. 01) 64
    PubMedGoogle Scholar
  • 5 Ferry JD, Miller M, Shulman S. The conversion of fibrinogen to fibrin. VII. Rigidity and stress relaxation of fibrin clots. Arch Biochem Biophys 1951; 34: 424-436
    PubMedGoogle Scholar